The short version: BPC-157 and TB-500 are the two most searched recovery-research peptides in Canada, and they are compared constantly. But asking which one is “better” is like asking whether a city needs roads or trucks. One is studied for building the blood supply to damaged tissue. The other is studied for getting cells to move into it. This guide explains the difference, the research behind each, and why so many labs end up using both.
BPC-157 vs TB-500 at a glance
| BPC-157 | TB-500 | |
|---|---|---|
| Origin | Fragment of a protein in human gastric juice | Fragment of thymosin beta-4, an intracellular protein |
| Size | 15 amino acids (~1419.5 Da) | Short synthetic fragment of a 43-aa protein |
| Core mechanism studied | Angiogenesis, VEGFR2, nitric oxide signalling | Actin sequestration, cell migration |
| Strongest literature | Tendon, ligament and gut models | Dermal wound and cardiac models (as Tβ4) |
| Main research group | University of Zagreb (Sikirić) | NIH (Kleinman, Goldstein); UT Southwestern (Srivastava) |
| Stability note | Unusually stable in acidic conditions | Behaves like a typical peptide |
BPC-157: the blood-supply peptide
BPC-157 is a 15-amino-acid sequence taken from a larger protein found in gastric juice. Its claim to fame in the lab is breadth: it shows activity in models as different as tendon, ligament, gut lining and blood vessels.
The thread that ties most of that together is angiogenesis, the growth of new blood vessels. A 2017 study by Hsieh and colleagues in the Journal of Molecular Medicine associated BPC-157’s pro-angiogenic activity with activation and up-regulation of VEGFR2, the main receptor for vascular growth signals. Tendons and ligaments have a notoriously poor blood supply, so a molecule associated with vessel growth naturally became a tool for studying them.
Chang and colleagues (2011, Journal of Applied Physiology) added a second piece: in cultured tendon tissue, BPC-157 was associated with increased outgrowth, cell survival and tenocyte migration. Rat models of Achilles detachment (Krivic, 2006) and ligament transection (Cerovecki, 2010) reported better healing scores in treated groups.
Full details: BPC-157 in Canada: research, price and buying guide.
TB-500: the cell-migration peptide
TB-500 is built around the active region of thymosin beta-4 (Tβ4), one of the most abundant proteins inside human cells. Tβ4’s job is to hold a reserve of actin, the protein that forms the cell’s internal skeleton, and release it when the cell needs to move or change shape.
That makes it a tool for studying cell migration. After an injury, nearby cells have to crawl into the damaged area, and that movement depends on how quickly actin can be assembled and disassembled. Malinda and colleagues (1999, Journal of Investigative Dermatology) reported faster wound closure with Tβ4 in rats. Bock-Marquette and colleagues (2004, Nature) reported improved cardiomyocyte migration and survival after induced heart injury in mice.
Watch the name: almost all of the landmark papers used full-length thymosin beta-4, not the shorter TB-500 fragment. They explain why TB-500 is studied, not what a given vial will do.
Full details: TB-500 in Canada: research, price and buying guide.
Which tissues each has been studied in
| Research model | BPC-157 | TB-500 / Tβ4 |
|---|---|---|
| Tendon and ligament | Strong (cell + rat models) | Moderate, mostly animal |
| Skin wounds | Some | Strong (rat, mouse) |
| Heart | Limited | Strong (Nature 2004, 2007) |
| Gut lining | Strong (foundational area) | Limited |
| Blood vessel growth | Central mechanism | Reported, secondary |
Why researchers study them together
Because the mechanisms barely overlap, combining them lets a single study look at two bottlenecks of tissue repair at once: getting blood to the area, and getting cells into it. That pairing is so common that it picked up a nickname, the “Wolverine” stack.
Two practical options exist. A pre-mixed BPC-157 + TB-500 blend is simpler to handle and arrives in one vial. Separate vials of BPC-157 and TB-500 let a protocol set its own ratio. Labs focused on skin and collagen often go a step further with the GLOW blend, which adds GHK-Cu.
How labs choose between them
- Studying vascular supply, nitric oxide or gut models? BPC-157 has the deeper literature.
- Studying cell motility, wound closure or cardiac models? TB-500 / Tβ4 is the natural fit.
- Studying both bottlenecks of repair? The combination, either blended or separate.
- On a tight budget? BPC-157 is cheaper per mg, which often makes it the starting point.
Cost comparison in Canada
| Product | Best-value size | Price | Per mg |
|---|---|---|---|
| BPC-157 | 10 mg | $55.00 | $5.50 |
| TB-500 | 10 mg | $70.00 | $7.00 |
| BPC + TB-500 blend | 30 mg | $112.00 | $3.73 |
The 30 mg blend is the lowest cost per milligram of the three. All orders ship from inside Canada, and orders over $200 ship free.
Frequently asked questions
Cliquez sur une question pour afficher la réponse.
What is the main difference between BPC-157 and TB-500?
BPC-157 is studied mainly for blood-vessel growth and nitric oxide signalling. TB-500 is studied for actin regulation and cell migration.
Is BPC-157 or TB-500 better for tendon research?
BPC-157 has more tendon and ligament-specific studies. TB-500 is studied for the cell-migration step, which is why the two are often combined.
What is the Wolverine stack?
The nickname for BPC-157 and TB-500 studied together, combining their complementary mechanisms.
Can BPC-157 and TB-500 be bought as a blend?
Yes. TrueLabs offers a pre-mixed BPC-157 + TB-500 blend in 10, 20 and 30 mg vials, as well as each peptide separately.
Related reading
- Peptides for healing: every compound ranked by evidence
- BPC-157 and TB-500 together: the full stack guide
- TB-500 side effects: what the human trials show
- BPC-157 in Canada: the complete guide
- TB-500 in Canada: the complete guide
- GHK-Cu copper peptide guide
Selected research references
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774–780. PubMed
- Krivic A, et al. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157. J Orthop Res. 2006;24(5):982–989. PubMed
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364–368. PubMed
- Bock-Marquette I, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466–472. PubMed
All TrueLabs products are sold for in vitro and laboratory research use only. They are not intended for human or veterinary use, and nothing in this article is medical advice. If you are dealing with an injury, please talk to a doctor or physiotherapist.